A continuación aparece una instantánea de la página web tal y como aparecía en 22/4/2024 (la última vez que nuestro rastreador la visitó). Esta es la versión de la página que se usó para la clasificación de los resultados de búsqueda. Puede que la página haya cambiado desde la última vez que la guardamos en caché. Para ver lo que puede haber cambiado (sin la información destacada), ve a la página actual.
Bing no se hace responsable del contenido de esta página.
Ben Goldacre: We all worry about digital spies stealing our data – but now even the things we thought we were happy to share are being used in ways we don’t like. Why aren’t we making more of a fuss?
Ben Goldacre: We now know the government's Tamiflu stockpile wouldn't have done us much good in the event of a flu epidemic. But the secrecy surrounding clinical trials means there's a lot we don't know about other medicines we take
Ben Goldacre: Doctors like me can't give an informed view on the benefits of any treatment, let alone Tamiflu, because drugs firms aren't publishing all the evidence
If teachers want politicians to base policy on evidence, they need to accept that randomised trials are the way to show what works, argues Ben Goldacre
Why did we believe Princess Diana, and how would it feel to be under fire in Baghdad, with only the dying for company? Would a burkini be a hit in Oxford – and how did Hilary Mantel rate Kate Moss's perfume? Find out in memorable pieces from the past 20 years of the Guardian's daily features section
Ben Goldacre: Trials show that people who think they've done something healthy, even if they haven't, smoke more and believe they are invulnerable to diseases
When data gets creepy: the secrets we don’t realise we’re giving away